NovaBone Secures FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications

NovaBone Products, a UF Startup and a leader in synthetic bone graft solutions, has announced its latest milestone: FDA clearance for its bioactive synthetic bone graft, NovaBone Putty, now expanded for use in the intervertebral disc space. This clearance marks an important addition to NovaBone’s existing portfolio, extending the use of NovaBone Putty for interbody fusion procedures to support a broader range of spinal and orthopedic surgical needs.